F.Y.I.: Flint Youth Injury Study (FYI)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01152970 |
Recruitment Status :
Completed
First Posted : June 29, 2010
Last Update Posted : August 10, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Drug Usage |
Study Type : | Observational |
Actual Enrollment : | 638 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Substance Use Among Violently Injured Youth in Urban ER: Services & Outcomes |
Study Start Date : | November 2009 |
Actual Primary Completion Date : | October 2013 |
Actual Study Completion Date : | December 2013 |
Group/Cohort |
---|
drug-using youth with violent injury
Youth(ages 14-24) who report illicit drug use and who present to an urban ED for an acute violent injury
|
drug-using youth with non-violent injury
Youth(ages 14-24) who report illicit drug use and who present to an urban ED for non-violence related care
|
- substance use as assessed with both the Mini-International Neuropsychiatric Interview [ Time Frame: Change from baseline substance use at 24 month ]
- substance use as assessed with the National Institute on Drug Abuse- Modified Alcohol, Smoking and Substance Involvement Screening Test [ Time Frame: Change from baseline substance use at 24 month ]
- violence behaviors as assessed with the modified Conflict Tactic Scale [ Time Frame: Change from baseline violence behaviors at 24 month ]
- HIV risk behaviors as assessed with the Risk Assessment Battery [ Time Frame: Change from baseline HIV risk behaviors at 24 month ]
- trajectories of participants' interactions with health services during the two years following their ED visit for an acute violent injury or for non-violence related care [ Time Frame: through the study completion, over 24 months ]Services will include substance abuse treatment, mental health services, and medical services including ED recidivism and HIV testing as assessed through chart review

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 14 Years to 24 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Inclusion criteria for screening:
- youth (ages 14-24) presenting to the Hurley Medical Center (HMC) ED who are medically stable. Patients classified by medical staff as having unstable vital signs or "Level 1" trauma (e.g., unconscious, in need of immediate lifesaving procedures such as surgery), will be approached during their inpatient stay after stabilization (4% based on prior work);
- access to a parent or guardian for consent among adolescents ages 14-17 (over 90% based on our prior work).
Positive substance use screen criteria: Youth will be eligible for the longitudinal study if they endorse on self-report computer survey past year use of illicit drugs (e.g. marijuana, cocaine, inhalants, non-prescribed use of psychoactive prescription drugs, etc).-
Exclusion Criteria:
- youth who do not understand English
- youth deemed unable to provide informed assent/consent by ED or research staff
- prisoners at time of ED presentation.
- youth who present to the ED as victims of sexual abuse or child abuse -

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01152970
United States, Michigan | |
Hurley Medical Center Emergency Department | |
Flint, Michigan, United States, 48503 |
Principal Investigator: | Rebecca Cunningham, MD | University of Michigan |
Responsible Party: | Rebecca Cunningham, Professor, University of Michigan |
ClinicalTrials.gov Identifier: | NCT01152970 |
Other Study ID Numbers: |
DA024646 01A2 R01DA024646-01A2 ( U.S. NIH Grant/Contract ) |
First Posted: | June 29, 2010 Key Record Dates |
Last Update Posted: | August 10, 2016 |
Last Verified: | August 2016 |